PharmacyCodes



Tonopres en es it fr

Tonopres Brand names, Tonopres Analogs

Tonopres Brand Names Mixture

  • No information avaliable

Tonopres Chemical_Formula

C33H37N5O5

Tonopres RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Tonopres fda sheet

Tonopres FDA

Tonopres msds (material safety sheet)

Tonopres MSDS

Tonopres Synthesis Reference

No information avaliable

Tonopres Molecular Weight

583.678 g/mol

Tonopres Melting Point

No information avaliable

Tonopres H2O Solubility

No information avaliable

Tonopres State

Solid

Tonopres LogP

No information avaliable

Tonopres Dosage Forms

Liquid

Tonopres Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Tonopres Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Tonopres Absorption

Interpatient variable and may be dependent on the administration technique

Tonopres side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Tonopres Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Tonopres Organisms Affected

Humans and other mammals